Stocks · Health care · Biological Products, (No Diagnostic Substances)

Invivyd, Inc.

IVVD Clue Score60
United States Fiscal year ends December CIK 0001832038 Results filed 13 Aug 2026

What the insiders did Net buying

By person

14 insiders · 61 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Mithril II LP entity
10% owner
$33.95M (1)
—
+$33.95M
11,241,580
$9.48M
—
Ajay Royan
Director
$33.95M (1)
—
+$33.95M
11,241,580
$9.48M
—
Redmile Group, LLC entity
10% owner
$24.99M (1)
—
+$24.99M
3,390,960
$2.86M
—
Adimab, LLC entity
10% owner
—
$19.75M (1)
−$19.75M
21,687,906
$18.28M
+992.4%
Marc Elia
Chief Executive Officer
$12.19M (3)
—
+$12.19M
9,248,250
$7.80M
+44.5%
Terrance McGuire
Director
$8.50M (6)
$1.02M (16)
+$7.48M
3,564,417
$3.00M
—
Jill Andersen
Chief Legal Officer, Secretary
—
$208.04K (6) scheduled
−$208.04K
283,774
$239.19K
+12,799%
Kevin F McLaughlin
Director
$125.00K (1)
—
+$125.00K
50,000
$42.15K
—
William E. Duke
Chief Financial Officer
—
$124.83K (6) scheduled
−$124.83K
168,937
$142.40K
—
Julie Green
Chief Human Resources Officer
—
$124.83K (6) scheduled
−$124.83K
168,937
$142.40K
—
Timothy Edward Lee
Chief Commercial Officer
—
$124.83K (6) scheduled
−$124.83K
178,937
$150.83K
+1,689%
Robert D. Allen III
Chief Scientific Officer
—
$115.47K (6) scheduled
−$115.47K
178,765
$150.68K
—
David Hering
Chief Executive Officer
$36.16K (1)
—
+$36.16K
8,000
$6.74K
—
Tillman U. Gerngross
Chief Executive Officer
—
—
—
27,845,995
$23.47M
+1,303%

No percentages here. This company's share count has moved by a factor of 2.5 over the window, from 119,961,445 to 294,758,746 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.